Polypharmacology rescored: Protein-ligand interaction profiles for remote binding site similarity assessment

Progress in Biophysics and Molecular Biology

Volumn 116, Issue 2-3, 2014, Pages 174-186

  Salentin, Sebastian ^a   Haupt, V Joachim ^a   Daminelli, Simone ^a   Schroeder, Michael ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Binding site similarity; Drug repositioning; Fingerprints; Polypharmacology; Profiling; Protein ligand interactions

Indexed keywords

LIGAND; MOLECULAR LIBRARY; PROTEIN; PROTEIN BINDING;

BINDING SITE; CHEMISTRY; METABOLISM; MOLECULAR LIBRARY; POLYPHARMACOLOGY;

BINDING SITES; LIGANDS; POLYPHARMACOLOGY; PROTEIN BINDING; PROTEINS; SMALL MOLECULE LIBRARIES;

EID: 84924026602     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2014.05.006     Document Type: Article

References (87)

1. An J., Totrov M., Abagyan R. Pocketome via comprehensive identification and classification of ligand binding envelopes. Mol. Cell. Proteom. 2005, 4:752-761.
2. Ashburn T.T., Thor K.B. Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug. Discov. 2004, 3:673-683.
3. Barlow D.J., Thornton J.M. Ion-pairs in proteins. J.Mol. Biol. 1983, 168:867-885.
4. Baron R., McCammon J.A. Molecular recognition and ligand association. Annu. Rev. Phys. Chem. 2013, 64:151-175.
5. Batista J., Tan L., Bajorath J. Atom-centered interacting fragments and similarity search applications. J.Chem. Inf. Model 2010, 50:79-86.
6. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. The protein data bank. Nucle 2000, 28:235-242.
7. Bissantz C., Kuhn B., Stahl M. Amedicinal chemist's guide to molecular interactions. J.Med. Chem. 2010, 53:5061-5084.
8. Brandt W., Haupt V.J., Wessjohann L.A. Cheminformatic analysis of biologically active macrocycles. Curr. Top. Med. Chem. 2010, 10:1361-1379.
9. Burley S.K., Petsko G.A. Aromatic-aromatic interaction: a mechanism of protein structure stabilization. Science 1985, 229:23-28.
10. Caboche S. Leview: automatic and interactive generation of 2d diagrams for biomacromolecule/ligand interactions. J.cheminformatics 2013, 5:40.
11. Cai C., Gong J., Liu X., Gao D., Li H. Simg: an alignment based method for evaluating the similarity of small molecules and binding sites. J.Chem. Inf. Model 2013, 53:2103-2115.
12. Capra J.A., Laskowski R.A., Thornton J.M., Singh M., Funkhouser T.A. Predicting protein ligand binding sites by combining evolutionary sequence conservation and 3d structure. PLoS Comput Biol. 2009, 5:e1000585.
13. Chakrabarti P., Bhattacharyya R. Geometry of nonbonded interactions involving planar groups in proteins. Prog. Biophys. Mol. Biol. 2007, 95:83-137.
14. Chen K., Kurgan L. Investigation of atomic level patterns in protein-small ligand interactions. PLoS One 2009, 4:e4473.
15. Chuaqui C., Deng Z., Singh J. Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening. J.Med. Chem. 2005, 48:121-133.
16. Chupakhin V., Marcou G., Baskin I., Varnek A., Rognan D. Predicting ligand binding modes from neural networks trained on protein-ligand interaction fingerprints. J.Chem. Inf. Model. 2013, 53:763-772.
17. Clark A.M., Labute P. 2d depiction of protein-ligand complexes. J.Chem. Inf. Model 2007, 47:1933-1944.
18. Crisman T.J., Sisay M.T., Bajorath J. Ligand-target interaction-based weighting of substructures for virtual screening. J.Chem. Inf. Model 2008, 48:1955-1964.
19. Deng Z., Chuaqui C., Singh J. Structural interaction fingerprint (sift): a novel method for analyzing three-dimensional protein-ligand binding interactions. J.Med. Chem. 2004, 47:337-344.
20. Deng Z., Chuaqui C., Singh J. Knowledge-based design of target-focused libraries using protein-ligand interaction constraints. J.Med. Chem. 2006, 49:490-500.
21. Desaphy J., Raimbaud E., Ducrot P., Rognan D. Encoding protein-ligand interaction patterns in fingerprints and graphs. J.Chem. Inf. Model. 2013, 53:623-637.
22. Durrant J., McCammon J. Binana: a novel algorithm for ligand-binding characterization. J.Mol. Graph. Model. 2011, 29:888-893.
23. Eldridge M.D., Murray C.W., Auton T.R., Paolini G.V., Mee R.P. Empirical scoring functions: I. the development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J.Comput Aided Mol. Des. 1997, 11:425-445.
24. Friesner R., Repasky M. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J.Med. Chem. 2006, 49:6177-6196.
25. Gallina A.M., Bork P., Bordo D. Structural analysis of protein-ligand interactions: the binding of endogenous compounds and of synthetic drugs. J.Mol. Recognit. 2014, 27:65-72.
26. Gallivan J.P., Dougherty D.a. Cation-pi interactions in structural biology. Proc. Natl. Acad. Sci. U S A. 1999, 96:9459-9464.
27. Gao M., Skolnick J. Acomprehensive survey of small-molecule binding pockets in proteins. PLoS Comput Biol. 2013, 9:e1003302.
28. Günther S., Senger C., Michalsky E., Goede A., Preissner R. Representation of target-bound drugs by computed conformers: implications for conformational libraries. BMC Bioinforma. 2006, 7:293.
29. Haupt V.J., Schroeder M. Old friends in new guise: repositioning of known drugs with structural bioinformatics. Brief. Bioinform 2011, 12:312-326.
30. Haupt V.J., Daminelli S., Schroeder M. Drug promiscuity in pdb: protein binding site similarity is key. PLoS One 2013, 8:e65894.
31. Higueruelo A.P., Schreyer A., Bickerton G.R.J., Blundell T.L., Pitt W.R. What can we learn from the evolution of protein-ligand interactions to aid the design of new therapeutics?. PloS one 2012, 7:e51742.
32. Hubbard R., Haider M.K. Hydrogen bonds in proteins: role and strength. eLS 2001, 1:1-6.
33. Igarashi T., Araki S., Mori H., Takeda S. Crystal structures of catrocollastatin/vap2b reveal a dynamic, modular architecture of adam/adamalysin/reprolysin family proteins. FEBS Lett. 2007, 581:2416-2422.
34. Jalencas X., Mestres J. On the origins of drug polypharmacology. MedChemComm 2013, 4:80.
35. Jiang L., Kuhlman B., Kortemme T., Baker D. A"solvated rotamer" approach to modeling water-mediated hydrogen bonds at protein-protein interfaces. Proteins 2005, 58:893-904.
36. Kahraman A., Thornton J.M. Methods to characterize the structure of enzyme binding sites. Comput. Struct. Biol. 2008, 189-221.
37. Kahraman A., Morris R.J., Laskowski R.A., Thornton J.M. Shape variation in protein binding pockets and their ligands. J.Mol. Biol. 2007, 368:283-301.
38. Kasahara K., Shirota M., Kinoshita K. Comprehensive classification and diversity assessment of atomic contacts in protein-small ligand interactions. J.Chem. Inf. Model. 2013, 53:241-248.
39. Kellenberger E., Schalon C., Rognan D. How to measure the similarity between protein ligand-binding sites?. Curr. Comput-Aid Drug. 2008, 4:209-220.
40. Kelly M.D., Mancera R.L. Expanded interaction fingerprint method for analyzing ligand binding modes in docking and structure-based drug design. J.Chem. Inf.Comput. Sci. 2004, 44:1942-1951.
41. Klebe G., Böhm H. Energetic and entropic factors determining binding affinity in protein-ligand complexes. J.Recept. Signal 1997, 17.
42. Konc J., Janežič D. Probis algorithm for detection of structurally similar protein binding sites by local structural alignment. Bioinformatics 2010, 26:1160-1168.
43. Konc J., Cesnik T., Konc J.T., Penca M., Janežič D. Probis-database: precalculated binding site similarities and local pairwise alignments of pdb structures. J.Chem. Inf. Model 2012, 52:604-612.
44. von Korff M., Freyss J., Sander T. Flexophore, a new versatile 3d pharmacophore descriptor that considers molecular flexibility. J.Chem. Inf. Model 2008, 48:797-810.
45. Ladbury J.E. Just add water! the effect of water on the specificity of protein-ligand binding sites and its potential application to drug design. Chem. Biol. 1996, 3:973-980.
46. Laskowski R.A., Swindells M.B. Ligplot+: multiple ligand-protein interaction diagrams for drug discovery. J.Chem. Inf. Model 2011, 51:2778-2786.
47. Liu T., Altman R.B. Using multiple microenvironments to find similar ligand-binding sites: application to kinase inhibitor binding. PLoS Comput Biol. 2011, 7:e1002326.
48. Lu Y., Shi T., Wang Y., Yang H., Yan X., Luo X., Jiang H., Zhu W. Halogen bonding-a novel interaction for rational drug design?. J.Med. Chem. 2009, 52:2854-2862.
49. Marcou G., Rognan D. Optimizing fragment and scaffold docking by use of molecular interaction fingerprints. J.Chem. Inf. Model. 2007, 47:195-207.
50. Mordalski S., Kosciolek T., Kristiansen K., Sylte I., Bojarski A.J. Protein binding site analysis by means of structural interaction fingerprint patterns. Bioorg Med. Chem. Lett. 2011, 21:6816-6819.
51. Mpamhanga C.P., Chen B., McLay I.M., Willett P. Knowledge-based interaction fingerprint scoring: a simple method for improving the effectiveness of fast scoring functions. J.Chem. Inf. Model. 2006, 46:686-698.
52. Muegge I., Martin Y.C. Ageneral and fast scoring function for protein-ligand interactions: a simplified potential approach. J.Med. Chem. 1999, 42:791-804.
53. Müller-Dethlefs K., Hobza P. Noncovalent interactions: a challenge for experiment and theory. Chem. Rev. 2000, 100:143-168.
54. Najmanovich R., Kuttner J., Sobolev V., Edelman M. Side-chain flexibility in proteins upon ligand binding. Proteins 2000, 39:261-268.
55. Nandigam R.K., Kim S., Singh J., Chuaqui C. Position specific interaction dependent scoring technique for virtual screening based on weighted protein-ligand interaction fingerprint profiles. J.Chem. Inf. Model 2009, 49:1185-1192.
56. Panigrahi S.K., Desiraju G.R. Strong and weak hydrogen bonds in the protein-ligand interface. Proteins 2007, 67:128-141.
57. Perez-Nueno V.I., Rabal O., Borrell J.I., Teixidó J. Apif: a new interaction fingerprint based on atom pairs and its application to virtual screening. J.Chem. Inf. Model. 2009, 49:1245-1260.
58. Politzer P., Lane P., Concha M.C., Ma Y., Murray J.S. An overview of halogen bonding. J.Mol. Model. 2007, 13:305-311.
59. Radifar M., Yuniarti N., Istyastono E.P. Pyplif: Python-based protein-ligand interaction fingerprinting. Bioinformation 2013, 9:325-328.
60. Rognan D. Structure-based approaches to target fishing and ligand profiling. Mol. Inf. 2010, 29:176-187.
61. Samsonov S., Teyra J., Pisabarro M.T. Amolecular dynamics approach to study the importance of solvent in protein interactions. Proteins: Struct. Funct. Bioinforma. 2008, 73:515-525.
62. Sato T., Honma T., Yokoyama S. Combining machine learning and pharmacophore-based interaction fingerprint for in silico screening. J.Chem. Inf. Model. 2010, 50:170-185.
63. Schalon C., Surgand J.S., Kellenberger E., Rognan D. Asimple and fuzzy method to align and compare druggable ligand-binding sites. Proteins 2008, 71:1755-1778.
64. Schreyer A., Blundell T. Credo: a protein-ligand interaction database for drug discovery. Chem. Biol. Drug. Des. 2009, 73:157-167.
65. Shulman-Peleg A., Shatsky M., Nussinov R., Wolfson H.J. Multibind and mappis: webservers for multiple alignment of protein 3d-binding sites and their interactions. Nucleic Acids Res. 2008, 36:W260-W264.
66. Sinnokrot M.O., Valeev E.F., Sherrill C.D. Estimates of the ab initio limit for pi-pi interactions: the benzene dimer. J.Am. Chem. Soc. 2002, 124:10887-10893.
67. Sirimulla S., Bailey J.B., Vegesna R., Narayan M. Halogen interactions in protein-ligand complexes: implications of halogen bonding for rational drug design. J.Chem. Inf. Model 2013, 53:2781-2791.
68. Skolnick J., Gao M. Interplay of physics and evolution in the likely origin of protein biochemical function. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:9344-9349.
69. Sobolev V., Sorokine A., Prilusky J., Abola E.E., Edelman M. Automated analysis of interatomic contacts in proteins. Bioinformatics 1999, 15:327-332.
70. Steiner T. The whole palette of hydrogen bonds. Angew. Chem. 2002, 41:48-76.
71. Stierand K., Rarey M. Drawing the pdb: protein-ligand complexes in two dimensions. ACS Med. Chem. Lett. 2010, 1:540-545.
72. Sturm N., Desaphy J., Quinn R.J., Rognan D., Kellenberger E. Structural insights into the molecular basis of the ligand promiscuity. J.Chem. Inf. Model 2012, 52:2410-2421.
73. Tan L., Bajorath J. Utilizing target-ligand interaction information in fingerprint searching for ligands of related targets. Chem. Biol. Drug. Des. 2009, 74:25-32.
74. Tan L., Lounkine E., Bajorath J. Similarity searching using fingerprints of molecular fragments involved in protein-ligand interactions. J.Chem. Inf. Model 2008, 48:2308-2312.
75. Tan L., Vogt M., Bajorath J. Three-dimensional protein-ligand interaction scaling of two-dimensional fingerprints. Chem. Biol. Drug. Des. 2009, 74:449-456.
76. Tan L., Batista J., Bajorath J. Computational methodologies for compound database searching that utilize experimental protein-ligand interaction information. Chem. Biol. Drug. Des. 2010, 76:191-200.
77. Teyra J., Pisabarro M. Characterization of interfacial solvent in protein complexes and contribution of wet spots to the interface description. Proteins: Struct. Funct. Bioinforma. 2007, 1095:1087-1095.
78. Turk B.E., Wong T.Y., Schwarzenbacher R., Jarrell E.T., Leppla S.H., Collier R.J., Liddington R.C., Cantley L.C. The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor. Nat. Struct. Mol. Biol. 2004, 11:60-66.
79. Venhorst J., Nunez S., Terpstra J.W., Kruse C.G. Assessment of scaffold hopping efficiency by use of molecular interaction fingerprints. J.Med. Chem. 2008, 51:3222-3229.
80. Verdonk M.L., Cole J.C., Hartshorn M.J., Murray C.W., Taylor R.D. Improved protein-ligand docking using gold. Proteins 2003, 52:609-623.
81. Waters M. Aromatic interactions in model systems. Curr. Opin. Chem. Biol. 2002, 736-741.
82. Weill N., Rognan D. Alignment-free ultra-high-throughput comparison of druggable protein-ligand binding sites. J.Chem. Inf. Model 2010, 50:123-135.
83. Wolber G., Langer T. Ligandscout: 3-d pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J.Chem. Inf. Model. 2005, 45:160-169.
84. Xie L., Wang J., Bourne P.E. In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators. PLoS Comput Biol. 2007, 3:e217.
85. Xie L., Xie L., Bourne P.E. Aunified statistical model to support local sequence order independent similarity searching for ligand-binding sites and its application to genome-based drug discovery. Bioinformatics 2009, 25:i305-i312.
86. Xu D., Tasi C., Nussinov R. Hydrogen bonds and salt bridges across protein-protein interfaces. Protein Eng. 1997, 10:999-1012.
87. Zacharias N., Dougherty D.A. Cation-pi interactions in ligand recognition and catalysis. Trends Pharmacol. Sci. 2002, 23:281-287.